These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18413774)

  • 1. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.
    Press OA; Zhang W; Gordon MA; Yang D; Lurje G; Iqbal S; El-Khoueiry A; Lenz HJ
    Cancer Res; 2008 Apr; 68(8):3037-42. PubMed ID: 18413774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
    Zhang W; Park DJ; Lu B; Yang DY; Gordon M; Groshen S; Yun J; Press OA; Vallböhmer D; Rhodes K; Lenz HJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):600-5. PubMed ID: 15701846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Wang HS; Su Y
    Clin Cancer Res; 2007 Jun; 13(12):3597-604. PubMed ID: 17575224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
    Zhang W; Press OA; Haiman CA; Yang DY; Gordon MA; Fazzone W; El-Khoueiry A; Iqbal S; Sherrod AE; Lurje G; Lenz HJ
    J Clin Oncol; 2007 Aug; 25(24):3726-31. PubMed ID: 17704422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
    Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
    Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor gene polymorphisms, R497K, but not (CA)n repeat, is associated with dilated cardiomyopathy.
    Zhou B; Rao L; Peng Y; Zhang Q; Zhang L
    Clin Chim Acta; 2009 May; 403(1-2):184-7. PubMed ID: 19265688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.
    Brandt B; Meyer-Staeckling S; Schmidt H; Agelopoulos K; Buerger H
    Clin Cancer Res; 2006 Dec; 12(24):7252-60. PubMed ID: 17189396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
    Lai CY; Sung FC; Hsieh LL; Tang R; Chiou HY; Wu FY; Yeh CC
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S599-606. PubMed ID: 23800895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma.
    Suzuki M; Kageyama S; Shinmura K; Okudela K; Bunai T; Nagura K; Igarashi H; Kiyose S; Mori H; Tao H; Goto M; Takamochi K; Mochizuki T; Suzuki K; Ohashi R; Ogawa H; Yamada T; Niwa H; Tsuneyoshi T; Sugimura H
    J Surg Oncol; 2008 Nov; 98(6):457-61. PubMed ID: 18683191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.
    Buerger H; Packeisen J; Boecker A; Tidow N; Kersting C; Bielawski K; Isola J; Yatabe Y; Nakachi K; Boecker W; Brandt B
    J Pathol; 2004 May; 203(1):545-50. PubMed ID: 15095477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
    Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
    Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.
    Press OA; Zhang W; Gordon MA; Yang D; Haiman CA; Azuma M; Iqbal S; Lenz HJ
    Pharmacogenomics J; 2011 Oct; 11(5):375-82. PubMed ID: 20548329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression.
    Buerger H; Gebhardt F; Schmidt H; Beckmann A; Hutmacher K; Simon R; Lelle R; Boecker W; Brandt B
    Cancer Res; 2000 Feb; 60(4):854-7. PubMed ID: 10706093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.
    Takahari D; Yamada Y; Okita NT; Honda T; Hirashima Y; Matsubara J; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Oncology; 2009; 76(1):42-8. PubMed ID: 19033715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of EGFR genetic variants on glioma risk and patient outcome.
    Costa BM; Viana-Pereira M; Fernandes R; Costa S; Linhares P; Vaz R; Pinheiro C; Lima J; Soares P; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires MM; Pinheiro C; Carvalho E; Oliveira P; Lopes JM; Reis RM
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2610-7. PubMed ID: 21960689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.
    Lurje G; Hendifar AE; Schultheis AM; Pohl A; Husain H; Yang D; Manegold PC; Ning Y; Zhang W; Lenz HJ
    Pharmacogenet Genomics; 2009 Feb; 19(2):95-102. PubMed ID: 18987561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.
    Dassoulas K; Gazouli M; Rizos S; Theodoropoulos G; Christoni Z; Nikiteas N; Karakitsos P
    Mol Carcinog; 2009 Jun; 48(6):563-9. PubMed ID: 19009560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.